HIV Genomic Aging Project in Oncology (HIV-GAP)
肿瘤学中的 HIV 基因组衰老项目 (HIV-GAP)
基本信息
- 批准号:10403025
- 负责人:
- 金额:$ 77.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-20 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAccountingAddressAgeAgingBiologicalBiological AgingBiological MarkersBloodBlood CellsCancer BurdenCancer CenterCancer PatientCancer RelapseCardiovascular DiseasesCause of DeathCessation of lifeChronic DiseaseChronologyClinicalClinical ManagementConsentDNADNA MethylationDataDevelopmentDiagnosisDiseaseEnsureEpigenetic ProcessEvaluationEvolutionFemaleFutureGait speedGastrointestinal NeoplasmsGenderGeneral PopulationGenomicsGoalsGynecologicGynecologic OncologyHIVHIV SeronegativityHematopoiesisHematopoietic stem cellsImmune System DiseasesIncidenceIndividualInferiorInflammationInstitutesInstitutionInvestigationKnowledgeLeadLife ExpectancyLinkMalignant NeoplasmsMeasuresModificationMonitorMutationNeoplasm MetastasisOncologyOutcomePatientsPersonsPrevalenceProcessPrognosisProtocols documentationRaceRecurrent diseaseRefractoryRisk FactorsRoleSample SizeSamplingSelection for TreatmentsSiteSolid NeoplasmTimeTranslatingTumor TissueVital StatusWorkadverse outcomeage groupage relatedanti agingantiretroviral therapybasebead chipcancer complicationcancer diagnosiscancer therapycohortexperiencefollow-upfunctional statusgastrointestinalgenomic biomarkerimprovedinstrumental activity of daily livingmalemenmortalitymortality risknext generation sequencingnovelnovel strategiesprogramsprospectivesample collectiontooltranslational impacttumor
项目摘要
ABSTRACT. People with HIV (PWH) experience higher cancer mortality and increased likelihood of cancer
relapse after initial therapy compared to HIV-uninfected cancer patients. Our prior work demonstrated that these
HIV-associated cancer outcome disparities persist after accounting for known risk factors. A novel approach to
identify targetable drivers of the poor cancer outcomes experienced by PWH is urgently needed to improve
prognosis. We posit that cancer outcomes in PWH are negatively impacted by prolonged immune dysfunction
that results in accelerated biological aging. Biological aging can be quantified using genomic biomarkers, such
as DNA methylation translated into epigenetic clocks and presence of age-related clonal hematopoiesis (ARCH).
The overarching goal of this proposal is to compare biological age, measured using genomic biomarkers,
between cancer patients with versus without HIV and to quantify associations between measured biological age
with important clinical outcomes. Previous studies in PWH (without cancer) indicate that HIV-infected individuals
have higher biological age, calculated using blood-based epigenetic clocks, compared to their chronological age.
This accelerated aging was associated with increased mortality. ARCH has also been reportedly increased in
PWH. ARCH is characterized by acquired mutations that expand over time in blood cells. Accumulation of these
mutations is linked to increased inflammation and adverse outcomes. Data suggest that ARCH may be twice as
prevalent in PWH (without cancer) compared to HIV-uninfected persons. Thus, there is evidence for a link
between HIV and advanced genomic aging in PWH (without cancer), which warrants exploration in the context
of cancer. To preliminarily explore our hypothesis, we sequenced blood DNA from 30 solid tumor patients (15
PWH and 15 HIV-uninfected) matched on chronological age. Our preliminary data indicate that genomic aging
is more advanced in cancer patients with HIV. We observed significantly higher epigenetic-based biological age
in the PWH. We detected ARCH mutations in 3 PWH but 0 HIV-uninfected patients. The median survival in PWH
was only 2 years, compared to 9 years in HIV-uninfected patients; most striking was the <1-year median survival
in the PWH with ARCH. In this proposal, we will utilize an established protocol at Moffitt Cancer Center and
Huntsman Cancer Institute to prospectively collect biospecimens from 400 cancer patients (200 with and 200
without HIV). The investigation is timely and compelling given that cancer is now a leading cause of death in
PWH, and incidence is increasing. We propose the following aims: 1) Compare the biological age of cancer
patients with versus without HIV using epigenetic clocks; 2) Compare baseline prevalence and therapy-related
evolution of ARCH between cancer patients with and without HIV; and 3) Quantify the association between
genomic biomarkers of aging and clinical outcomes, including aging-related functional assessments. This study
will address the critical knowledge gap of whether cancer patients with HIV are biologically older than age-
matched cancer patients without HIV, and whether this advanced aging contributes to poor cancer outcomes.
抽象的。艾滋病毒携带者(PWH)经历更高的癌症死亡率和更高的癌症可能性
与未感染艾滋病毒的癌症患者相比,初次治疗后复发。我们之前的工作表明,这些
在考虑了已知的风险因素后,与艾滋病毒相关的癌症结果差异仍然存在。一种新的方法来
迫切需要找出导致威斯康星患者癌症预后不良的目标驱动因素
预后。我们假设长期免疫功能障碍对PWH患者的癌症预后有负面影响。
这导致了生物衰老的加速。生物老化可以使用基因组生物标记物来量化,例如
随着DNA甲基化转化为表观遗传时钟和年龄相关克隆性造血(ARCH)的存在。
这项建议的首要目标是比较使用基因组生物标记物测量的生物年龄,
HIV携带者和未携带HIV的癌症患者之间的关系以及测量的生物年龄之间的关联
具有重要的临床结果。之前在PWH(非癌症)上的研究表明,艾滋病毒感染者
使用基于血液的表观遗传学时钟计算的生物学年龄比他们的实际年龄更高。
这种加速的衰老与死亡率的增加有关。据报道,ARCH在#年也有所增加
威尔斯亲王医院。ARCH的特征是获得性突变,随着时间的推移,这些突变会在血细胞中扩大。这些东西的积累
突变与炎症增加和不良后果有关。数据表明,拱门可能是
与未感染艾滋病毒的人相比,在PWH(无癌症)中流行。因此,有证据表明两者之间存在联系
HIV与PWH(非癌症)的晚期基因组老化之间的关系,值得在此背景下进行探索
癌症的威胁。为了初步验证我们的假设,我们对30名实体肿瘤患者(15名)的血液DNA进行了测序
威斯康星医院和15名未感染艾滋病毒的人)在时间上年龄匹配。我们的初步数据表明基因组老化
在携带艾滋病毒的癌症患者中更为晚期。我们观察到显著更高的基于表观遗传学的生物学年龄
在威尔斯亲王医院。我们在3例PWH患者中检测到ARCH突变,但在未感染HIV的患者中未检测到ARCH突变。威尔斯亲王医院的中位生存期
只有两年,相比之下,未感染艾滋病毒的患者为九年;最令人震惊的是中位生存期为一年。
在有拱门的威斯康星医院里。在这份提案中,我们将利用莫菲特癌症中心的既定方案,并
亨斯迈癌症研究所将前瞻性地从400名癌症患者(200名癌症患者和200名癌症患者)中收集生物标本
没有艾滋病毒)。考虑到癌症现在是#年的主要死亡原因,这项调查是及时和令人信服的。
PWH,发病率呈上升趋势。我们提出了以下目标:1)比较癌症的生物学年龄
使用表观遗传学时钟比较HIV携带者和非HIV携带者;2)比较基线患病率和治疗相关
癌症患者与HIV携带者之间ARCH的演变;以及3)量化两者之间的关联
衰老和临床结果的基因组生物标记物,包括与衰老相关的功能评估。本研究
将解决关键的知识差距,即携带艾滋病毒的癌症患者在生物学上是否比年龄更大-
匹配没有艾滋病毒的癌症患者,以及这种高龄是否导致较差的癌症结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Coghill其他文献
Anna Coghill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Coghill', 18)}}的其他基金
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
生物衰老对赞比亚艾滋病毒感染者免疫相关宫颈癌结果差异的影响
- 批准号:
10754783 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
HIV Genomic Aging Project in Oncology (HIV-GAP)
肿瘤学中的 HIV 基因组衰老项目 (HIV-GAP)
- 批准号:
10491212 - 财政年份:2021
- 资助金额:
$ 77.86万 - 项目类别:
HIV Genomic Aging Project in Oncology (HIV-GAP)
肿瘤学中的 HIV 基因组衰老项目 (HIV-GAP)
- 批准号:
10687211 - 财政年份:2021
- 资助金额:
$ 77.86万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 77.86万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 77.86万 - 项目类别: